TY - JOUR
T1 - Genetic and clinical determinants of abdominal aortic diameter
T2 - genome-wide association studies, exome array data and Mendelian randomization study
AU - Portilla-Fernandez, Eliana
AU - Klarin, Derek
AU - VA Million Veteran Program
AU - Hwang, Shih Jen
AU - Biggs, Mary L.
AU - Bis, Joshua C.
AU - Weiss, Stefan
AU - Rospleszcz, Susanne
AU - Natarajan, Pradeep
AU - Hoffmann, Udo
AU - Rogers, Ian S.
AU - Truong, Quynh A.
AU - Völker, Uwe
AU - Dörr, Marcus
AU - Bülow, Robin
AU - Criqui, Michael H.
AU - Allison, Matthew
AU - Ganesh, Santhi K.
AU - Yao, Jie
AU - Waldenberger, Melanie
AU - Bamberg, Fabian
AU - Rice, Kenneth M.
AU - Essers, Jeroen
AU - Kapteijn, Daniek M.C.
AU - van der Laan, Sander W.
AU - de Knegt, Rob J.
AU - Ghanbari, Mohsen
AU - Felix, Janine F.
AU - Ikram, M. Arfan
AU - Kavousi, Maryam
AU - Roks, Anton J.M.
AU - Uitterlinden, Andre G.
AU - Danser, A. H. Jan
AU - Tsao, Philip S.
AU - Damrauer, Scott M.
AU - Guo, Xiuqing
AU - Rotter, Jerome I.
AU - Psaty, Bruce M.
AU - Kathiresan, Sekar
AU - Völzke, Henry
AU - Peters, Annette
AU - Johnson, Craig
AU - Strauch, Konstantin
AU - Meitinger, Thomas
AU - O'Donnell, Christopher J.
AU - Dehghan, Abbas
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press.
PY - 2022/10/15
Y1 - 2022/10/15
N2 - Progressive dilation of the infrarenal aortic diameter is a consequence of the ageing process and is considered the main determinant of abdominal aortic aneurysm (AAA). We aimed to investigate the genetic and clinical determinants of abdominal aortic diameter (AAD). We conducted a meta-analysis of genome-wide association studies in 10 cohorts (n = 13 542) imputed to the 1000 Genome Project reference panel including 12 815 subjects in the discovery phase and 727 subjects [Partners Biobank cohort 1 (PBIO)] as replication. Maximum anterior-posterior diameter of the infrarenal aorta was used as AAD. We also included exome array data (n = 14 480) from seven epidemiologic studies. Single-variant and gene-based associations were done using SeqMeta package. A Mendelian randomization analysis was applied to investigate the causal effect of a number of clinical risk factors on AAD. In genome-wide association study (GWAS) on AAD, rs74448815 in the intronic region of LDLRAD4 reached genome-wide significance (beta = -0.02, SE = 0.004, P-value = 2.10 × 10-8). The association replicated in the PBIO1 cohort (P-value = 8.19 × 10-4). In exome-array single-variant analysis (P-value threshold = 9 × 10-7), the lowest P-value was found for rs239259 located in SLC22A20 (beta = 0.007, P-value = 1.2 × 10-5). In the gene-based analysis (P-value threshold = 1.85 × 10-6), PCSK5 showed an association with AAD (P-value = 8.03 × 10-7). Furthermore, in Mendelian randomization analyses, we found evidence for genetic association of pulse pressure (beta = -0.003, P-value = 0.02), triglycerides (beta = -0.16, P-value = 0.008) and height (beta = 0.03, P-value < 0.0001), known risk factors for AAA, consistent with a causal association with AAD. Our findings point to new biology as well as highlighting gene regions in mechanisms that have previously been implicated in the genetics of other vascular diseases.
AB - Progressive dilation of the infrarenal aortic diameter is a consequence of the ageing process and is considered the main determinant of abdominal aortic aneurysm (AAA). We aimed to investigate the genetic and clinical determinants of abdominal aortic diameter (AAD). We conducted a meta-analysis of genome-wide association studies in 10 cohorts (n = 13 542) imputed to the 1000 Genome Project reference panel including 12 815 subjects in the discovery phase and 727 subjects [Partners Biobank cohort 1 (PBIO)] as replication. Maximum anterior-posterior diameter of the infrarenal aorta was used as AAD. We also included exome array data (n = 14 480) from seven epidemiologic studies. Single-variant and gene-based associations were done using SeqMeta package. A Mendelian randomization analysis was applied to investigate the causal effect of a number of clinical risk factors on AAD. In genome-wide association study (GWAS) on AAD, rs74448815 in the intronic region of LDLRAD4 reached genome-wide significance (beta = -0.02, SE = 0.004, P-value = 2.10 × 10-8). The association replicated in the PBIO1 cohort (P-value = 8.19 × 10-4). In exome-array single-variant analysis (P-value threshold = 9 × 10-7), the lowest P-value was found for rs239259 located in SLC22A20 (beta = 0.007, P-value = 1.2 × 10-5). In the gene-based analysis (P-value threshold = 1.85 × 10-6), PCSK5 showed an association with AAD (P-value = 8.03 × 10-7). Furthermore, in Mendelian randomization analyses, we found evidence for genetic association of pulse pressure (beta = -0.003, P-value = 0.02), triglycerides (beta = -0.16, P-value = 0.008) and height (beta = 0.03, P-value < 0.0001), known risk factors for AAA, consistent with a causal association with AAD. Our findings point to new biology as well as highlighting gene regions in mechanisms that have previously been implicated in the genetics of other vascular diseases.
UR - http://www.scopus.com/inward/record.url?scp=85139804259&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddac051
DO - 10.1093/hmg/ddac051
M3 - Article
C2 - 35234888
AN - SCOPUS:85139804259
SN - 0964-6906
VL - 31
SP - 3566
EP - 3579
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 20
ER -